Insulet | PODD - Market Capitalization

Stock Price
251.30
Daily Change
-5.32 -2.07%
Monthly
-11.36%
Yearly
-9.76%
Q1 Forecast
247.93

Insulet reported $17.94B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 9.08B 4.65B Sep/2025
AtriCure USD 1.75B 130M Sep/2025
Avanos Medical USD 536M 30M Sep/2025
Baxter International USD 11.7B 3.84B Sep/2025
Becton, Dickinson and Co. USD 53.65B 4.28B Sep/2025
Boston Scientific USD 144.66B 14.24B Sep/2025
Cardinal Health USD 37.29B 2.81B Sep/2025
Cooper Companies USD 13.9B 205M Sep/2025
Dexcom USD 26.39B 7.84B Sep/2025
Edwards Lifesciences USD 45.66B 219M Sep/2025
Eli Lilly USD 722.15B 16.64B Sep/2025
Globus Medical USD 7.74B 255M Sep/2025
ICU Medical USD 2.96B 292M Sep/2025
Insulet USD 21.73B 374M Sep/2025
Integra LifeSciences USD 1.12B 163M Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Masimo USD 7.68B 1.44B Sep/2025
Medtronic USD 120.14B 1.06B Sep/2025
Merit Medical Systems USD 4.93B 591M Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 820M 422M Sep/2025
Teleflex USD 5.3B 73M Sep/2025
West Pharmaceutical Services USD 18.86B 3.14B Sep/2025
WK Kellogg Co USD 12.66B 464.02M Sep/2025
Zimmer Biomet Holdings USD 19.51B 1.47B Sep/2025